- Home
- AQST vs TOI Comparison
AQST vs TOI Comparison
Compare AQST & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQST
- TOI
- Stock Information
- Founded
- AQST 2004
- TOI 2007
- Country
- AQST United States
- TOI United States
- Employees
- AQST N/A
- TOI N/A
- Industry
- AQST Biotechnology: Pharmaceutical Preparations
- TOI Medical/Nursing Services
- Sector
- AQST Health Care
- TOI Health Care
- Exchange
- AQST Nasdaq
- TOI Nasdaq
- Market Cap
- AQST 272.9M
- TOI 266.8M
- IPO Year
- AQST 2018
- TOI N/A
- Fundamental
- Price
- AQST $4.07
- TOI $3.13
- Analyst Decision
- AQST Strong Buy
- TOI
- Analyst Count
- AQST 7
- TOI 0
- Target Price
- AQST $11.29
- TOI N/A
- AVG Volume (30 Days)
- AQST 1.3M
- TOI 2.1M
- Earning Date
- AQST 08-05-2025
- TOI 08-12-2025
- Dividend Yield
- AQST N/A
- TOI N/A
- EPS Growth
- AQST N/A
- TOI N/A
- EPS
- AQST N/A
- TOI N/A
- Revenue
- AQST $54,228,000.00
- TOI $403,152,000.00
- Revenue This Year
- AQST N/A
- TOI $23.95
- Revenue Next Year
- AQST $45.71
- TOI N/A
- P/E Ratio
- AQST N/A
- TOI N/A
- Revenue Growth
- AQST 5.29
- TOI 17.64
- 52 Week Low
- AQST $2.12
- TOI $0.13
- 52 Week High
- AQST $5.80
- TOI $3.50
- Technical
- Relative Strength Index (RSI)
- AQST 72.86
- TOI 65.30
- Support Level
- AQST $3.62
- TOI $2.35
- Resistance Level
- AQST $3.80
- TOI $2.64
- Average True Range (ATR)
- AQST 0.19
- TOI 0.24
- MACD
- AQST 0.05
- TOI 0.09
- Stochastic Oscillator
- AQST 95.43
- TOI 99.55
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
About TOI The Oncology Institute Inc.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.